基于截短脂寡糖-外膜蛋白偶联疫苗的抗卡他莫拉菌与不可分型流感嗜血杆菌免疫学特性
本研究将野生型和截短型卡他莫拉菌脱毒脂寡糖(LOS)与重组修饰OMP26(rOMP26VTAL)偶联,免疫小鼠后抗LOS和抗rOMP26VTAL IgG水平显著升高,抗血清对A、B血清型卡他莫拉菌及一株NTHi显示补体介导的杀菌活性。A、B血清型占分离株90%以上。作者认为该偶联物可作为疫苗组分,需在动物模型中进一步研究。
要点
- 截短型LOS与rOMP26VTAL偶联免疫小鼠可显著升高抗LOS和抗rOMP26VTAL IgG。
- 小鼠抗血清对A、B血清型卡他莫拉菌及一株NTHi有补体介导杀菌活性。
- A、B血清型占卡他莫拉菌分离株90%以上。
核心结论
- LOS与OMP偶联物可作为疫苗组分,需在动物模型中进一步研究。
研究设计与样本
- 将野生型和截短型卡他莫拉菌脱毒LOS与重组修饰OMP26(rOMP26VTAL)偶联,免疫小鼠并检测抗体与杀菌活性。
主要发现
- 免疫小鼠抗LOS和抗rOMP26VTAL IgG水平显著升高。
- 小鼠抗血清对全部受试A、B血清型卡他莫拉菌株及一株NTHi显示补体介导的杀菌活性。
- A、B血清型占卡他莫拉菌分离株90%以上。
局限性
- 作者结论指出需在动物模型中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Moraxella catarrhalis and nontypeable Haemophilus influenzae are important bacterial causes of otitis media in children and respiratory diseases in adults. Lipooligosaccharide (LOS) from M. catarrhalis and outer membrane protein 26 (OMP26) from NTHi are major surface antigens identified as potential vaccine components against these organisms. We previously constructed M. catarrhalis in which LOS is truncated, but contains a structure common to the three known serotypes of M. catarrhalis. OMP26 is known to enhance clearance of NTHi following vaccination in animal models, so was chosen as the carrier protein. In this study, we conjugated wild-type and truncated M. catarrhalis detoxified-LOS to a recombinant modified OMP26, rOMP26VTAL. Vaccination of mice with these conjugates resulted in a significant increase in anti-LOS and anti-rOMP26VTAL IgG levels. Importantly, mouse antisera showed complement-mediated bactericidal activity against all M. catarrhalis serotype A and B strains and a NTHi strain tested. Serotypes A & B make up more than 90% of isolates. These data suggest that the LOS and OMP based conjugate can be used as vaccine components and require further investigation in animal models.
引用
- Singh S, Wilson JC, Cripps AW, et al. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae. Vaccine. 2019. PMID: 31668366. doi:10.1016/j.vaccine.2019.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。